Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease

Clinical Endocrinology

Volumn 72, Issue 2, 2010, Pages 248-255

  Li Qun, Gu ^a   Wei, Zhu ^a   Shuang Xia, Zhao ^a   Lin, Zhao ^a   Min Jia, Zhang ^a   Bin, Cui ^a   Huai Dong, Song ^a   Guang, Ning ^a   Yong Ju, Zhao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN FCRL3; PROTEIN TG; PROTEIN TSHR; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HAPLOTYPES; HUMANS; LINEAR MODELS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 12; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RECEPTORS, IMMUNOLOGIC; RECEPTORS, THYROTROPIN;

EID: 74549152607     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03617.x     Document Type: Article

References (44)

1. Tomer, Y. Davies, T.F. (2003) Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocrine Reviews, 24, 694 717.
2. Jacobson, E.M. Tomer, Y. (2007) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. Journal of Autoimmunity, 28, 85 98.
3. Scheipers, P. Reiser, H. (1998) Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proceedings of the National Academy of Sciences of the United States of America, 95, 10083 10088.
4. Yanagawa, T., Hidaka, Y., Guimaraes, V. et al. (1995) CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. Journal of Clinical Endocrinology and Metabolism, 80, 41 45.
5. Kotsa, K., Watson, P.F. Weetman, A.P. (1997) A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clinical Endocrinology (Oxford), 46, 551 554.
6. Donner, H., Rau, H., Walfish, P.G. et al. (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 82, 143 146.
7. Kavvoura, F.K., Akamizu, T., Awata, T. et al. (2007) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 92, 3162 3170.
8. Tomer, Y., Greenberg, D.A., Concepcion, E. et al. (2002) Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism, 87, 404 407. (Pubitemid 34084722)
9. Hsiao, J.Y., Hsieh, M.C., Tien, K.J. et al. (2007) Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese. Journal of Clinical Endocrinology and Metabolism, 92, 3197 3201.
10. Hiratani, H., Bowden, D.W., Ikegami, S. et al. (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. Journal of Clinical Endocrinology and Metabolism, 90, 2898 2903.
11. Ho, S.C., Goh, S.S. Khoo, D.H. (2003) Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid, 13, 523 528.
12. Akamizu, T., Sale, M.M., Rich, S.S. et al. (2000) Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients. Thyroid, 10, 851 858.
13. Dechairo, B.M., Zabaneh, D., Collins, J. et al. (2005) Association of the TSHR gene with Graves' disease: the first disease specific locus. European Journal of Human Genetics, 13, 1223 1230.
14. Ichimura, M., Kaku, H., Fukutani, T. et al. (2008) Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid, 18, 625 630.
15. Velaga, M.R., Wilson, V., Jennings, C.E. et al. (2004) The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 89, 5862 5865.
16. Ban, Y., Tozaki, T., Taniyama, M. et al. (2005) The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid, 15, 1115 1118.
17. Syed, A.A., Simmonds, M.J., Brand, O.J. et al. (2007) Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy. Clinical Endocrinology (Oxford), 67, 663 667.
18. Chistiakov, D.A. Chistiakov, A.P. (2007) Is FCRL3 a new general autoimmunity gene? Human Immunology, 68, 375 383.
19. Kochi, Y., Yamada, R., Suzuki, A. et al. (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nature Genetics, 37, 478 485.
20. Ikari, K., Momohara, S., Nakamura, T. et al. (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Annals of the Rheumatic Diseases, 65, 671 673.
21. Simmonds, M.J., Heward, J.M., Carr-Smith, J. et al. (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 91, 1056 1061.
22. Heward, J.M., Brand, O.J., Barrett, J.C. et al. (2007) Association of PTPN22 haplotypes with Graves' disease. Journal of Clinical Endocrinology and Metabolism, 92, 685 690.
23. Wacholder, S., Chanock, S., Garcia-Closas, M. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. Journal of the National Cancer Institute, 96, 434 442.
24. Wang, P.W., Liu, R.T., Juo, S.H. et al. (2004) Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal. Journal of Clinical Endocrinology and Metabolism, 89, 169 173.
25. Wang, P.W., Chen, I.Y., Liu, R.T. et al. (2007) Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study. Journal of Clinical Endocrinology and Metabolism, 92, 2513 2518.
26. Tomer, Y. (2001) Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid, 11, 167 169.
27. Ban, Y., Greenberg, D.A., Concepcion, E. et al. (2003) Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proceedings of the National Academy of Sciences of the United States of America, 100, 15119 15124.
28. Collins, J.E., Heward, J.M., Howson, J.M. et al. (2004) Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. Journal of Clinical Endocrinology and Metabolism, 89, 6336 6339.
29. Anjos, S., Nguyen, A., Ounissi-Benkalha, H. et al. (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry, 277, 46478 46486.
30. Buck, D., Kroner, A., Rieckmann, P. et al. (2006) Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis. Tissue Antigens, 68, 335 338.
31. Hodge, S.E., Ban, Y., Strug, L.J. et al. (2006) Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid, 16, 351 355.
32. Manji, N., Carr-Smith, J.D., Boelaert, K. et al. (2006) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. Journal of Clinical Endocrinology and Metabolism, 91, 4873 4880.
33. Cloutier, J.F. Veillette, A. (1999) Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. Journal of Experimental Medicine, 189, 111 121.
34. Hill, R.J., Zozulya, S., Lu, Y.L. et al. (2002) The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Experimental Hematology, 30, 237 244.
35. Mustelin, T., Alonso, A., Bottini, N. et al. (2004) Protein tyrosine phosphatases in T cell physiology. Molecular Immunology, 41, 687 700. (Pubitemid 38824623)
36. Zhang, Z.H., Chen, F., Zhang, X.L. et al. (2008) PTPN22 allele polymorphisms in 15 Chinese populations. International Journal of Immunogenetics, 35, 433 437.
37. Davis, R.S., Wang, Y.H., Kubagawa, H. et al. (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proceedings of the National Academy of Sciences of the United States of America, 98, 9772 9777.
38. Davis, R.S., Dennis, G. Jr., Odom, M.R. et al. (2002) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunological Reviews, 190, 123 136.
39. Hu, X., Chang, M., Saiki, R.K. et al. (2006) The functional -169T - >C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis and Rheumatism, 54, 1022 1025.
40. Turunen, J.A., Wessman, M., Kilpikari, R. et al. (2006) The functional variant -169C/T in the FCRL3 gene does not increase susceptibility to Type 1 diabetes. Diabetic Medicine, 23, 925 927.
41. Owen, C.J., Kelly, H., Eden, J.A. et al. (2007) Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. Journal of Clinical Endocrinology and Metabolism, 92, 1106 1111.
42. Newman, W.G., Zhang, Q., Liu, X. et al. (2006) Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis and Rheumatism, 54, 3820 3827.
43. Colhoun, H.M., McKeigue, P.M. Davey Smith, G. (2003) Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865 872.
44. Dong, L.M., Potter, J.D., White, E. et al. (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423 2436.